HIGHLIGHTS
- who: Yang Zhang from the (UNIVERSITY) have published the research work: The chemokine CCL17 is a novel therapeutic target for cardiovascular aging, in the Journal: (JOURNAL) of 31/01/2023
SUMMARY
Received such as growth rate, social interactions, immune function, and stress response. For instance, SPF rats display abnormal hematological, hemodynamic, and hemostatic phenotypes in response to anesthetics. This may be a common limitation of most studies on aging and immunology and may complexify the translation of findings to human vascular function. Although the crosssectional population study revealed CCL17 level was positively correlated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.